Atlas Trials

Phase II Study of Single Agent OSI-7904L in Patients With Gastric or Gastroesophageal (GEJ) Cancer

Clinical trial NCT00073502 · COMPLETED

Trial details

NCT number
NCT00073502
Sponsor
OSI Pharmaceuticals
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Gastroesophageal AdenocarcinomaGastric Adenocarcinoma
Start date
2003-10-01
Enrollment
43

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.